Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
Reyes HD, Miecznikowski J, Gonzalez-Bosquet J, Devor EJ, Zhang Y, Thiel KW, Samuelson MI, McDonald M, Stephan JM, Hanjani P, Guntupalli S, Tewari KS, Backes F, Ramirez N, Fleming GF, Filiaci V, Birrer MJ, Leslie KK. Reyes HD, et al. Among authors: samuelson mi. Gynecol Oncol. 2017 Aug;146(2):247-253. doi: 10.1016/j.ygyno.2017.05.017. Epub 2017 May 19. Gynecol Oncol. 2017. PMID: 28532857 Free PMC article.
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Bender D, Sill MW, Lankes HA, Reyes HD, Darus CJ, Delmore JE, Rotmensch J, Gray HJ, Mannel RS, Schilder JM, Hunter MI, McCourt CK, Samuelson MI, Leslie KK. Bender D, et al. Among authors: samuelson mi. Gynecol Oncol. 2015 Sep;138(3):507-12. doi: 10.1016/j.ygyno.2015.07.018. Epub 2015 Jul 15. Gynecol Oncol. 2015. PMID: 26186911 Free PMC article. Clinical Trial.
Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.
Reyes HD, Carlson MJ, Devor EJ, Zhang Y, Thiel KW, Samuelson MI, McDonald M, Yang S, Stephan JM, Savage EC, Dai D, Goodheart MJ, Leslie KK. Reyes HD, et al. Among authors: samuelson mi. Gynecol Oncol. 2016 Jan;140(1):152-60. doi: 10.1016/j.ygyno.2015.10.023. Epub 2015 Oct 30. Gynecol Oncol. 2016. PMID: 26524723 Free PMC article.
A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response.
Duska LR, Filiaci VL, Walker JL, Holman LL, Hill EK, Moore RG, Ring KL, Pearl ML, Muller CY, Kushnir CL, Lankes HA, Samuelson MI, Carrick KS, Rajan A, Rodgers WH, Kohn EC, Piekarz R, Leslie KK. Duska LR, et al. Among authors: samuelson mi. Clin Cancer Res. 2021 May 15;27(10):2734-2741. doi: 10.1158/1078-0432.CCR-20-4618. Epub 2021 Mar 25. Clin Cancer Res. 2021. PMID: 33766814 Free PMC article. Clinical Trial.
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
Thiel KW, Devor EJ, Filiaci VL, Mutch D, Moxley K, Alvarez Secord A, Tewari KS, McDonald ME, Mathews C, Cosgrove C, Dewdney S, Aghajanian C, Samuelson MI, Lankes HA, Soslow RA, Leslie KK. Thiel KW, et al. Among authors: samuelson mi. J Clin Oncol. 2022 Oct 1;40(28):3289-3300. doi: 10.1200/JCO.21.02506. Epub 2022 Jun 3. J Clin Oncol. 2022. PMID: 35658479 Free PMC article. Clinical Trial.
Pure Primary Ovarian Carcinoid Tumor.
Halvorson TS, Robinson RA, Samuelson MI. Halvorson TS, et al. Among authors: samuelson mi. Int J Gynecol Pathol. 2021 May 1;40(3):301-304. doi: 10.1097/PGP.0000000000000675. Int J Gynecol Pathol. 2021. PMID: 32187084
Frozen Section Quality Assurance.
Laakman JM, Chen SJ, Lake KS, Blau JL, Rajan DA, Samuelson MI, Robinson RA. Laakman JM, et al. Among authors: samuelson mi. Am J Clin Pathol. 2021 Aug 4;156(3):461-470. doi: 10.1093/ajcp/aqaa259. Am J Clin Pathol. 2021. PMID: 33728460
21 results